Results 31 to 40 of about 209,409 (314)
Omalizumab as a Provoking Factor for Venous Thromboembolism
Drug Target Insights, 2019 A 43-year-old man with a history of severe extrinsic allergic asthma treated with once-monthly omalizumab (600 mg) for the last 15 months. He presented to the emergency room with a 2-week history of right lower limb pain and chest pleuritic pain ...
Crhistian-Mario Oblitas +4 more
doaj +1 more source
Portal Venous Thrombosis Associated with Use of Etonogestrel/ethinyl Estradiol Vaginal Ring [PDF]
, 2020 Introduction: Portal venous thrombosis is a life-threatening cause of abdominal pain. In younger patients, heritable thrombophilias, pregnancy, tobacco use, and oral contraceptives are associated.Case Report: A 26-year-old woman prescribed contraceptive ...
Bailey, Katelynn E. +1 more
core
DVT Surveillance Program in the ICU: Analysis of Cost-Effectiveness [PDF]
, 2014 Background Venous Thrombo-embolism (VTE – Deep venous thrombosis (DVT) and/or pulmonary embolism (PE) – in traumatized patients causes significant morbidity and mortality.
Aboutanos, Michel B. +10 more
core +3 more sources
Direct Oral Anticoagulants for the Treatment of Unusual-Site Venous Thrombosis: An Update
PharmaceuticsDirect oral anticoagulants (DOACs) have emerged as the preferred oral anticoagulant therapy for patients with deep vein thrombosis of the lower extremities and pulmonary embolism. DOACs offer several advantages over vitamin K antagonists, including fixed
Anabel Franco-Moreno +4 more
doaj +1 more source
Proteus Syndrome: A Rare Case in An Adult Ward
European Journal of Case Reports in Internal Medicine, 2021 Proteus syndrome is an extremely rare disorder that manifests as an asymmetric, disproportionate overgrowth of any connective tissue, such as bone, fat or epidermal nevi, in a mosaic or patchy pattern.
Catarina Duarte Santos +6 more
doaj +1 more source
Research and Practice in Thrombosis and Haemostasis, 2020 Background The COVID‐19 pandemic has focused medical attention on treating affected patients and protecting others from infection. However, concerns have been raised regarding the pandemic´s impact and associated containment measures (eg curfew, lockdown)
Stephan Nopp +6 more
doaj +1 more source
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021 Background Blood pressure (BP) variability has reportedly been a risk factor for various clinical events. To clarify the influence of BP visit‐to‐visit variability on adverse events in patients with nonvalvular atrial fibrillation, a post hoc analysis of
Eitaro Kodani +6 more
doaj +1 more source
Impact of Asymptomatic Intracranial Hemorrhage on Outcome After Endovascular Stroke Treatment
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Background Endovascular treatment (EVT) achieves high rates of recanalization in acute large‐vessel occlusion (LVO) stroke, but functional recovery remains heterogeneous. While symptomatic intracranial hemorrhage (sICH) has been well studied, the prognostic impact of asymptomatic intracranial hemorrhage (aICH) after EVT is less certain ...
Shihai Yang +22 more
wiley +1 more source
Cyclic thrombocytopenia with statistically significant neutrophil oscillations
Clinical Case Reports, 2018 Key Clinical Message Cyclic thrombocytopenia is often misdiagnosed as immune thrombocytopenia due to similar clinical features, a fact of significance because cyclic thrombocytopenia generally responds poorly to treatments used successfully in immune ...
Gabriel P. Langlois +5 more
doaj +1 more source
Lung surfactant alterations in pulmonary thromboembolism
European Journal of Medical Research, 2009 Beside neonatal respiratory distress syndrome, secondary surfactant deficiency may occur in patients with mature lungs. Recent studies revealed quantitative and qualitative changes of lung surfactant in pulmonary thromboembolism (PTE) concerning the ...
Calkovska A, Mokra D, Calkovsky V
doaj +1 more source